BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Evotec OAI (Germany) (DX:EVT) To Present At The 2005 UBS Global Healthcare Services Conference


10/19/2005 5:12:40 PM

HAMBURG, Germany and OXFORD, England, February 9 /PRNewswire-FirstCall/ -- Evotec OAI today announced that Dr Dirk Ehlers, CFO of Evotec OAI, will present at the UBS Global Healthcare Services Conference at 01.00 p.m. ET on Tuesday, 15 February 2005, at The Plaza in New York City.

The audio portion of the presentation will be a webcast via the UBS website at http://www.ibb.ubs.com/. The accompanying slides are available on request. Please e-mail to: investor.relations@evotecoai.com.

About Evotec OAI AG

Evotec OAI is a leader in the discovery and development of the next generation of novel small molecule based drugs through both contract research partnerships and discovery programmes for out-licensing. The Company provides innovative solutions from target to clinic through an unmatched range of integrated capabilities ranging from assay development and screening through to medicinal chemistry and drug manufacturing. As a result, Evotec OAI has established itself as the partner of choice for pharmaceutical and biotechnology companies worldwide. With over 600 people located in Hamburg, Germany and near Oxford, UK, Evotec OAI is committed to generate value to its partners, shareholders and employees through a sustainable strategy that balances short-term and long-term business opportunities.

http://www.evotecoai.com/ Contact: Evotec OAI AG Anne Hennecke Director Investor Relations & Corporate Communications Phone: +49-(0)40-5-60-81-286 anne.hennecke@evotecoai.com

Evotec OAI AG

CONTACT: Contact: Evotec OAI AG, Anne Hennecke, Director InvestorRelations & Corporate Communications, Phone:+49-(0)40-5-60-81-286 anne.hennecke@evotecoai.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES